on “Endpoints used in Relative Effectiveness Assessment - Safety”. This consultation will take place between 21 October and 17 November 2015.
The guideline has been revised for language changes and supplements necessary to extend the scope of text and recommendations from pharmaceuticals to non-drug interventions with a special focus on medical devices. The revised document can be found here.